Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022304

Expand all

NUCYNTA (TAPENTADOL HYDROCHLORIDE)
EQ 50MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022304
Product Number: 001
Approval Date: Nov 20, 2008
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
NUCYNTA (TAPENTADOL HYDROCHLORIDE)
EQ 75MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022304
Product Number: 002
Approval Date: Nov 20, 2008
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
NUCYNTA (TAPENTADOL HYDROCHLORIDE)
EQ 100MG BASE
Marketing Status: Prescription
Active Ingredient: TAPENTADOL HYDROCHLORIDE
Proprietary Name: NUCYNTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022304
Product Number: 003
Approval Date: Nov 20, 2008
Applicant Holder Full Name: COLLEGIUM PHARMACEUTICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English